IRCT201705016312N4已完成未知
Effect of Vitamin E and Pioglitazone in patients with non-alcoholic fatty liver disease in Marvdasht Hospital
Vice chancellor for research, Shiraz University Of Medical Science0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: Patients with NAFLD confirmed by performing liver sonography and increased levels of liver enzymes AST and ALT.
排除标准
- •History of alcohol consumption; diabetes; chronic liver disease; use of drugs such as statin, fibrate.
研究者
相似试验
进行中（未招募）
不适用
Effect of pioglitazone in patienst with Adrenomyeloneuropathy.X-linked adrenoleukodystrophyEUCTR2011-006113-34-ESAURORA PUJOL ONOFRE
招募中
不适用
The effect of pioglitazone on reducing opioid and heroin dependence.IRCT20190427043389N2Zanjan University of Medical Sciences100
招募中
不适用
The effect of pioglitazone on reducing methamphetamine dependence.Methamphetamine dependent patients.IRCT20190427043389N1Zanjan University of Medical Sciences100
进行中（未招募）
不适用
Effect of Pioglitazone compared to a combination therapy with Ramipril and to a Ramipril monotherapy on low grade inflammation and vascular function in patients with increased cardiovascular risk and an activated inflammationA randomized double-blinded phase II studyon-diabetic hypertensive patients with a hsCRP value > 1.0 mg/L < 10.0 mg/L and pretreated with ACE inhibitors for at least 12 weeks are eligible for study participation.MedDRA version: 8.1Level: LLTClassification code 10003601Term: AtherosclerosisEUCTR2006-004028-35-DETakeda Pharma GmbH
招募中
3 期
Effect of Pioglitazone and ClobetasolIRCT20210926052596N1Tehran University of Medical Sciences40